Patent ID: 11857550
Assignee: THE UNITED STATES GOVERNMENT AS REPRESENTED BY THE DEPARTMENT OF VETERANS AFFAIRS
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C  Y | IPC A  C

Claim 9:
10. A method for treating an FBXO3-mediated disorder or injury in a subject in need thereof, the method comprising administering to the subject a therapeutically effective amount of the compound, , or a pharmaceutically acceptable salt thereof;
wherein the FBXO3-mediated disorder or injury is at least one selected from malaria, toxic lung exposure, cancer, Alzheimer's, and a burn-related injury;
wherein the cancer is at least one selected from leukemia, lymphoma, bronchogenic carcinoma, adenocarcinoma of the breast, colon, ovary, thyroid, pancreas, stomach, or prostate, squamous cell cancer, small cell cancer, melanoma, sarcoma, and metastatic cancer.